Revel Pharmaceuticals
Revel Pharmaceuticals is a biotechnology commercializing therapeutic enzymes to degrade age associated molecule damage. We are targeting pathological, age associated compounds known as Advanced Glycation End Products (AGEs) which build up on long lived proteins like collagen. AGE accumulation is implicated in multiple diseases of aging, thus Revel Pharmaceuticals is strategically positioned to develop therapeutics across multiple indications.
7-day free trial · no credit card
Verified contacts
8
available on Kipplo
LinkedIn employees
7
1 to 10 range
Open roles
—
no listings
Distinct roles
7
indexed titles
Tech stack
2
tools in use
Monthly traffic
266
organic / mo
Sign up free to see all 8 verified contacts at Revel Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
8 contacts with verified email or phone · masked until revealed.
- AC
Aaron Cravens
Chief Executive Officer · Other
EmailPhone - NT
Narisa Trabosh
Associate Scientist · Research & Development
EmailPhone - SH
Sam Hedley
Research Associate · Science
EmailPhone
Showing 3 of 8 verified contacts
Top roles at Revel Pharmaceuticals
7 distinct titles indexed · top 7 shown.
- 1associate scientist
- 1chief executive officer
- 1head of enzyme engineering
- 1independent contractor
- 1research associate
- 1scientist
- 1scientist ii
Sign up to unlock all 8 contacts at Revel Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 8 verified contacts at Revel Pharmaceuticals
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.